Evidence map›Paper›PMID 28942089›Full record

ArticleJournal of molecular biology2017

Biochemical Basis for Distinct Roles of the Heterochromatin Proteins Swi6 and Chp2.

R Stefan Isaac, Serena Sanulli, Ryan Tibble, Michael Hornsby, Matthew Ravalin, Charles S Craik, John D Gross, Geeta J Narlikar

Abstract read
In one paragraph

Article in Journal of molecular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Biophysical Properties of HP1-Mediated Heterochromatin.Cold Spring Harbor symposia on quantitative biology · 2019
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

R Stefan IsaacDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158 United States; Tetrad Graduate Program, University of California, San Francisco, San Francisco, CA, 94158 United States.
Serena SanulliProgram in Chemistry and Chemical Biology, University of California, San Francisco, San Francisco, CA, 94158 United States; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158 United States.
Ryan TibbleProgram in Chemistry and Chemical Biology, University of California, San Francisco, San Francisco, CA, 94158 United States; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158 United States.
Michael HornsbyDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158 United States.
Matthew RavalinDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158 United States.
Charles S CraikDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158 United States.
John D GrossProgram in Chemistry and Chemical Biology, University of California, San Francisco, San Francisco, CA, 94158 United States; Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, 94158 United States.
Geeta J NarlikarDepartment of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, 94158 United States. Electronic address: geeta.narlikar@ucsf.edu.
University of California, San Francisco · US

Funding

RESEARCH TRAINING IN CHEMISTRY AND CHEMICAL BIOLOGYT32GM064337 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2002 to 2021
$7.8M
Renewable antibodies to secreted proteins and single and multi-pass cell surfaceP41CA196276 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2014 to 2018
$5.8M
Structure and Function of the Decapping Enzyme ComplexR01GM078360 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, JOHN D · 2009 to 2018
$2.5M
Conformational Control of Heterochromatin Formation by the HP-1 Protein fromFission YeastR01GM121962 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GROSS, JOHN D · 2017 to 2020
$1.9M
Mechanistic dissection of HP1 mediated heterochromatinR01GM108455 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NARLIKAR, GEETA J · 2014 to 2017
$1.7M
Allosteric Inhibition of a Family of Proteolytic EnzymesR01GM104659 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIK, CHARLES SCOTT · 2013 to 2016
$1.2M
NCI NIH HHS P41 CA196276NIGMS NIH HHS R01 GM078360NIGMS NIH HHS R01 GM104659NIGMS NIH HHS R01 GM108455NIGMS NIH HHS R01 GM121962NIGMS NIH HHS T32 GM064337
6 · The paper itself

Abstract

Heterochromatin protein 1 (HP1) family proteins are conserved chromatin binding proteins involved in gene silencing, chromosome packaging, and chromosome segregation. These proteins recognize histone H3 lysine 9 methylated tails via their chromodomain and recruit additional ligand proteins with diverse activities through their dimerization domain, the chromoshadow domain. Species that have HP1 proteins possess multiple paralogs that perform non-overlapping roles in vivo. How different HP1 proteins, which are highly conserved, perform different functions is not well understood. Here, we use the two Schizosaccharomyces pombe HP1 paralogs, Swi6 and Chp2, as model systems to compare and contrast their biophysical properties. We find that Swi6 and Chp2 have similar dimerization and oligomerization equilibria, and that Swi6 binds slightly (~3-fold) more strongly to nucleosomes than Chp2. Furthermore, while Swi6 binding to the H3K9me3 mark is regulated by a previously described auto-inhibition mechanism, the binding of Chp2 to the H3K9me3 mark is not analogously regulated. In the context of chromoshadow domain interactions, we show using a newly identified peptide sequence from the Clr3 histone deacetylase and a previously identified sequence from the protein Shugoshin that the Swi6 chromoshadow domain binds both ligands more strongly than the Chp2. Overall, our findings uncover quantitative differences in how Swi6 and Chp2 interact with nucleosomal and non-nucleosomal ligands and qualitative differences in how their assembly on nucleosomes is regulated. These findings provide a biochemical framework to explain the varied functions of Chp2 and Swi6 in vivo.

Indexed as

Chromatin Assembly and DisassemblyChromosomal Proteins, Non-HistoneHeterochromatinHistone DeacetylasesHistonesNucleosomesProtein ConformationRepressor ProteinsSchizosaccharomycesSchizosaccharomyces pombe ProteinsCHP2 protein, S pombeChromosomal Proteins, Non-HistoneHeterochromatinHistone DeacetylasesHistonesNucleosomesRepressor ProteinsSchizosaccharomyces pombe ProteinsSwi6 protein, S pombeanalytical ultracentrifugationheterochromatinNMRSchizosaccharomyces pombe

Identifiers

PMID28942089
PMCPMC5693750
OpenAlexW2756057625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.